4
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-26-064656
Options or other derivatives
- Director acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HARTOUNIAN HARTOUN Director | 2026-02-26 | Grant or award · Stock Option (Right to Buy) | +225,000 | $0.70 | $157,500 | 225,000 | D: show line 1 in the form |
Loading xslF345X06/tm267728-4_4seq1.xml…